logo-loader
viewOzop Surgical Corp.

Ozop rises as company gives vision for minimally invasive spinal surgery

The company said expected 2019-2020 milestones include establishing a team of surgeons and other experts in the development of Balloon Lumbar Interbody Fusion technology

A person with an aching back
The company seeks to make a difference for people suffering from back pain

Ozop Surgical Corp (OTCMKTS:OZSC) rose Monday as the surgical device company said it is moving forward with its plans to use medical-quality balloons in minimally invasive spinal surgery.

The company said expected 2019-2020 milestones include establishing a team of surgeons and other experts in the development of Balloon Lumbar Interbody Fusion (BLIF) technology.

Shares of Ozop climbed 6.3% to $0.85 in Monday’s OTC Markets trading.

READ: Ozop Surgical recognized as a top 10 orthopedic products provider by Med Tech Outlook magazine

Ozop is also expecting to complete all necessary testing for Food and Drug Administration (FDA) submission in the next two years. Upon approval, the company plans to build sets, complete a robust training regimen and begin "an alpha launch at key centers."

In 2018, the company said it began development of an enhanced expandable anterior lumbar interbody fusion (ALIF) implant with initial designs and prototypes completed.

The company expects to complete design and testing in the first half of 2019 and expects FDA approval in the second half.

“We are happy with our accomplishments to date and realize we have a lot of work ahead of us to achieve our goals and objectives for 2019 and beyond,”  CEO Michael Chermak said in a statement. “I thank all of our shareholders and investors for the confidence they have shown in our company.”

He added that he looks forward to making “a significant impact” for people suffering from back pain as well as on the healthcare industry as a whole.

Contact Dennis Fitzgerald at [email protected]

Quick facts: Ozop Surgical Corp.

Price: 0.0117 USD

OTCMKTS:OZSC
Market: OTCMKTS
Market Cap: $414.97 k
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ozop Surgical Corp. named herein, including the promotion by the Company of Ozop Surgical Corp. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OZOP Surgical makes headway on bringing its spine implant tech to market

OZOP Surgical Corp (OTCQB:OZSC) COO Thomas McLeer tells Proactive Investors the medical device company is making headway with its surgical implant devices. McLeer says over the next year the Florida based company is developing the first percutaneous spinal fusion implant system to allow...

on 01/15/2019

2 min read